Hypertension Dr. Elizabeth Swiggum, Cardiologist Dr. Anthony Nielsen, Medical Lead CVRR. - ppt download
RLC_RJS_RRH Risk Engine_abstract_ADA 2012 WEB
A Pen-and-Paper Coronary Risk Estimator for Office Use With Patients With Type 2 Diabetes
Comparison of cardiovascular risk calculators in patients with diabetes
Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study | BMC Endocrine Disorders
Cardiovascular risk algorithms in primary care: Results from the DETECT study | Scientific Reports
UKPDS 60 | Stroke
UOA01-18- Planning for a Future with Diabetes- Tools to Assess Diabetes Risk and Outcomes
EPIRxISK
EPIRxISK
Agreement Among Cardiovascular Disease Risk Calculators | Circulation
Calculadora UKPDS-RE: após preencher as informações solicitadas no... | Download Scientific Diagram
Example of calculating cardiovascular risk with the use of a UKPDS... | Download Scientific Diagram
UKPDS Risk Engine | Cardiovascular Complications | Metabolic Syndrome
Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care
SciELO - Brasil - Estimation of cardiovascular risk and detection of subclinical carotid atheromatosis in patients with diabetes without a history of cardiovascular disease Estimation of cardiovascular risk and detection of subclinical
Table 1 from External Validation of the UKPDS Risk Engine in Incident Type 2 Diabetes: A Need for New Type 2 Diabetes–Specific Risk Equations | Semantic Scholar
UKPDS-CV Risk by Headcan
The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in
Calculating risk in patients with type 2 diabetes in The Netherlands: UKPDS versus ZODIAC risk engine performance (ZODIAC-26) - Media Centre | EASD
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) - The Lancet
UKPDS Risk : Cloud Practice
UKPDS-CV Risk by Headcan
